267
Views
2
CrossRef citations to date
0
Altmetric
Invited Reviews

The Role of Radiotherapy in Orbital Pseudotumor: A Systematic Review of Literature

, MDORCID Icon, , MD, , MD, , MD, , MD, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD & , MD show all
Pages 1162-1167 | Received 28 Oct 2020, Accepted 29 Dec 2020, Published online: 09 Feb 2021

References

  • Yuen SJA, Rubin PAD. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491–499. doi:10.1001/archopht.121.4.491.
  • Gordon LK. Diagnostic dilemmas in orbital inflammatory disease. Ocul Immunol Inflamm. 2003 Mar;11(1):3–15. doi:10.1076/ocii.11.1.3.15577.
  • Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 montgomery lecture, part 1. Ophthalmology. 2004 May;111(5):997–1008. doi:10.1016/j.ophtha.2003.01.002.
  • Birch-Hirschfeld A. Zur Diagnostik und Patholgie der Orbitaltumoren. Dtsch Ophthalmol Ges. 1905;32:127–135.
  • Fujii H, Fujisada H, Kondo T, et al. Orbital pseudotumor: histopathological classification and treatment. Ophthalmologica. 1985;190(4):230–242. doi:10.1159/000309523.
  • Swamy BN, McCluskey P, Nemet A, et al. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. Dec 2007;91(12):1667–1670. doi:10.1136/bjo.2007.124156.
  • Mendenhall WM, Lessner AM. Orbital pseudotumor. Am J Clin Oncol. 2010;33(3):304–306. doi:10.1097/COC.0b013e3181a07567.
  • Smitt MC, Donaldson SS. Radiation therapy for benign disease of the orbit. Semin Radiat Oncol. 1999;9(2):179–189. doi:10.1016/S1053-4296(99)80008-3.
  • Hahn E, Laperriere N, Millar BA, et al. Orbital radiation therapy for Graves’ ophthalmopathy: measuring clinical efficacy and impact. Pract Radiat Oncol. Jul-Aug 2014;4(4):233–239. doi:10.1016/j.prro.2014.02.008.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. Published 2009 Jul 21. doi:10.1136/bmj.b2700.
  • Kim RY, Roth RE. Radiotherapy of orbital pseudotumor. Radiology. 1978;127(2):507–509. doi:10.1148/127.2.507.
  • Kennerdell JS, Johnson BL, Deutsch M. Radiation treatment of orbital lymphoid hyperplasia. Ophthalmology. 1979;86(5):942–947. doi:10.1016/S0161-6420(79)35439-2.
  • Donaldson SS, McDougall IR, Egbert PR, et al. Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys. 1980;6(1):79–86. doi:10.1016/0360-3016(80)90207-2.
  • Sergott RC, Glaser JS, Charyulu K. Radiotherapy for idiopathic inflammatory orbital pseudotumor. Indications and results. Arch Ophthalmol. 1981;99(5):853–856. doi:10.1001/archopht.1981.03930010853013.
  • Orcutt JC, Garner A, Henk JM, et al. Treatment of idiopathic inflammatory orbital pseudotumours by radiotherapy. Br J Ophthalmol. 1983;67(9):570–574. doi:10.1136/bjo.67.9.570.
  • Jereb B, Lee H, Jakobiec FA, et al. Radiation therapy of conjunctival and orbital lymphoid tumors. Int J Radiat Oncol Biol Phys. 1984;10(7):1013–1019. doi:10.1016/0360-3016(84)90172-X.
  • Fitzpatrick PJ, Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys. 1984;10(3):333–340. doi:10.1016/0360-3016(84)90051-8.
  • Leone CR Jr, Lloyd WC 3rd. Treatment protocol for orbital inflammatory disease. Ophthalmology. 1985;92(10):1325–1331. doi:10.1016/S0161-6420(85)33854-X.
  • Austin-Seymour MM, Donaldson SS, Egbert PR, et al. Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys. 1985;11(2):371–379. doi:10.1016/0360-3016(85)90160-9.
  • Gordon PS, Juillard GJ, Selch MT, et al. Orbital lymphomas and pseudolymphomas: treatment with radiation therapy. Radiology. 1986;159(3):797–799. doi:10.1148/radiology.159.3.3085143.
  • Mittal BB, Deutsch M, Kennerdell J, et al. Paraocular lymphoid tumors. Radiology. 1986;159(3):793–796. doi:10.1148/radiology.159.3.3704159.
  • Lanciano R, Fowble B, Sergott RC, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18(2):407–411. doi:10.1016/0360-3016(90)90108-V.
  • Notter M, Kern T, Forrer A, et al. Radiotherapy of pseudotumor orbitae. Front Radiat Ther Oncol. 1997;30:180–191.
  • Hsuan JD, Selva D, McNab AA, et al. Idiopathic sclerosing orbital inflammation. Arch Ophthalmol. Sep 2006;124(9):1244–1250. doi:10.1001/archopht.124.9.1244.
  • Matthiesen C, Bogardus C Jr, Thompson JS, et al. The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys. 2011;79(5):1496–1502. doi:10.1016/j.ijrobp.2009.12.071.
  • Lee JH, Kim YS, Yang SW, et al. Radiotherapy with or without surgery for patients with idiopathic sclerosing orbital inflammation refractory or intolerant to steroid therapy. Int J Radiat Oncol Biol Phys. Sep 1 2012;84(1):52–58. doi:10.1016/j.ijrobp.2011.11.031.
  • Prabhu RS, Kandula S, Liebman L, et al. Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(3):643–649. doi:10.1016/j.ijrobp.2012.06.033.
  • Yaprak G, Kasim K, Isık N, et al. Efficient treatment of resistant orbital pseudotumor with cyberknife: case series and short review of literature. South Clin Ist Euras. 2018;29(3):198–202.
  • Mokhtech M, Nurkic S, Morris CG, et al. Radiotherapy for orbital pseudotumor: the university of florida experience. Cancer Invest. 2018;36(6):330–337. doi:10.1080/07357907.2018.1489550.
  • Marwaha G, Macklis R, Singh AD. Radiation therapy: orbital tumors. Dev Ophthalmol. 2013;52:94–101.
  • Yeşiltaş YS, Gündüz AK. Idiopathic orbital inflammation: review of literature and new advances. Middle East Afr J Ophthalmol. 2018;25(2):71–80. doi:10.4103/meajo.MEAJO_44_18.
  • Mod H, Jha AK. Review of radiation therapy in benign ocular diseases. J Nepal Health Res Counc. 2014;12:130–137.
  • Espinoza GM. Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep. 2010;12(6):443–447. doi:10.1007/s11926-010-0128-8.
  • Mombaerts I, Bilyk JR, Rose GE, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified delphi approach. JAMA Ophthalmol. 2017;135(7):769–776. doi:10.1001/jamaophthalmol.2017.1581.
  • Carruth BP, Wladis EJ. Inflammatory modulators and biologic agents in the treatment of idiopathic orbital inflammation.Curr. Opin Ophthamol. 2012;23:420–426. doi:10.1097/ICU.0b013e328355715e.
  • Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol. 2002;13(6):347–351. doi:10.1097/00055735-200212000-00001.
  • Finger PT. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol. 2009;54(5):545–568. doi:10.1016/j.survophthal.2009.06.004.
  • Tagliaferri L, Bussu F, Fionda B, et al. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review. Tumori. 2017;103(6):516–524. doi:10.5301/tj.5000614.
  • Tagliaferri L, Pagliara MM, Fionda B, et al. Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review. J Contemp Brachytherapy. 2019;11(1):54–60. doi:10.5114/jcb.2019.82888.
  • Pagliara MM, Tagliaferri L, Lenkowicz J, et al. AVATAR: analysis for visual acuity prediction after eye interventional radiotherapy. Vivo. 2020;34(1):381–387. doi:10.21873/invivo.11784.
  • Tagliaferri L, Budrukkar A, Lenkowicz J, et al. ENT COBRA ONTOLOGY: the covariates classification system proposed by the head & neck and skin GEC-ESTRO working group for interdisciplinary standardized data collection in head and neck patient cohorts treated with interventional radiotherapy (brachytherapy). J Contemp Brachytherapy. 2018;10(3):260–266. doi:10.5114/jcb.2018.76982.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.